BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27781036)

  • 1. Modulation of Primary Immune Response by Different Vaccine Adjuvants.
    Ciabattini A; Pettini E; Fiorino F; Pastore G; Andersen P; Pozzi G; Medaglini D
    Front Immunol; 2016; 7():427. PubMed ID: 27781036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System.
    Ciabattini A; Pettini E; Fiorino F; Lucchesi S; Pastore G; Brunetti J; Santoro F; Andersen P; Bracci L; Pozzi G; Medaglini D
    Front Immunol; 2018; 9():380. PubMed ID: 29593710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes.
    Ciabattini A; Prota G; Christensen D; Andersen P; Pozzi G; Medaglini D
    Front Immunol; 2015; 6():430. PubMed ID: 26379666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomics of the Vaccine Immune Response: Priming With Adjuvant Modulates Recall Innate Responses After Boosting.
    Santoro F; Pettini E; Kazmin D; Ciabattini A; Fiorino F; Gilfillan GD; Evenroed IM; Andersen P; Pozzi G; Medaglini D
    Front Immunol; 2018; 9():1248. PubMed ID: 29922291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation.
    Prota G; Christensen D; Andersen P; Medaglini D; Ciabattini A
    Vaccine; 2015 Nov; 33(48):6823-30. PubMed ID: 26494626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
    Pettini E; Pastore G; Fiorino F; Medaglini D; Ciabattini A
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33804604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
    Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S
    Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses.
    Pedersen GK; Wørzner K; Andersen P; Christensen D
    Front Immunol; 2020; 11():579761. PubMed ID: 33072125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.
    Kamath AT; Mastelic B; Christensen D; Rochat AF; Agger EM; Pinschewer DD; Andersen P; Lambert PH; Siegrist CA
    J Immunol; 2012 May; 188(10):4828-37. PubMed ID: 22504654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
    Valensi JP; Carlson JR; Van Nest GA
    J Immunol; 1994 Nov; 153(9):4029-39. PubMed ID: 7930610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo.
    Linghua Z; Xingshan T; Fengzhen Z
    Int Immunopharmacol; 2006 Aug; 6(8):1267-76. PubMed ID: 16782539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response.
    Fiorino F; Pettini E; Pozzi G; Medaglini D; Ciabattini A
    Front Immunol; 2013; 4():128. PubMed ID: 23755051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the CD4(+) T cell response after acellular pertussis vaccination in the presence of TLR4 ligation.
    Brummelman J; Helm K; Hamstra HJ; van der Ley P; Boog CJ; Han WG; van Els CA
    Vaccine; 2015 Mar; 33(12):1483-91. PubMed ID: 25659267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants.
    Mastelic B; Kamath AT; Fontannaz P; Tougne C; Rochat AF; Belnoue E; Combescure C; Auderset F; Lambert PH; Tacchini-Cottier F; Siegrist CA
    J Immunol; 2012 Dec; 189(12):5764-72. PubMed ID: 23162125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.
    Desbien AL; Reed SJ; Bailor HR; Dubois Cauwelaert N; Laurance JD; Orr MT; Fox CB; Carter D; Reed SG; Duthie MS
    Eur J Immunol; 2015 Feb; 45(2):407-17. PubMed ID: 25367751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
    Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on adjuvants for human prophylactics. II. Influence of the route of injection on the activity of adjuvants to tetanus toxoid in guinea pigs.
    Yamamoto A; Murata R
    Jpn J Med Sci Biol; 1978; 31(5-6):393-406. PubMed ID: 156804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.